HHS, FDA heads in China
This article was originally published in The Tan Sheet
Executive Summary
Health and Human Services Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach are in China the week of Nov. 17 to consult with their Chinese counterparts, conduct two workshops and open offices in three cities, HHS says Nov. 13. The U.S. and Chinese officials will discuss the recent melamine contamination of dairy products and strategies to improve food and consumer product safety in both countries. In October, Leavitt announced a timeline for opening FDA offices in the Chinese cities of Shanghai, Beijing and Guangzhou, as well as New Delhi, India, during the remainder of 2008 (1"The Tan Sheet" Oct. 20, 2008, In Brief)
You may also be interested in...
FDA overseas offices open by year-end
Health and Human Services Secretary Mike Leavitt lays out a timeline Oct. 16 for opening and staffing foreign FDA offices to work with local authorities and industries that export to the U.S. China will be first, with FDA staffers slated to begin in Beijing by the end of 2008 and other offices opening in Shanghai and Guangzhou next year. FDA also will open an office in New Delhi, India, in 2008. "Opening these offices will mark a key milestone in the globalization of our efforts to enhance the safety of imported food and medical products," Leavitt says. Working closely with foreign regulators is a large component of FDA's Import Safety Action Plan, but dietary supplement industry stakeholders have warned that overseas offices will siphon resources from other agency programs (1"The Tan Sheet" Oct. 13, 2008, p. 12 and 2"The Tan Sheet" Feb. 11, 2008, p. 3)
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.